Therefore, to better assess the sensibility and specificity of CRP dosage and FiO2 at the admission as possible mortality predictors in COVID-19 in an unvaccinated population, a ROC curve analysis was conducted, including all patients (Fig. 1). The gene discussed is CRP; the disease is COVID-19.